Primary systemic therapy in patients with breast cancer: rationale of use and magnitude of evidence

Author： Puglisi Fabio   Minisini Alessandro   Piga Andrea  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.1, Iss.1, 2004-09, pp. : 91-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: Primary Systemic Therapy for Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 66-66

Bentham Science Publishers

Access to resources Recommend Favorite

Prognosis for patients with metastatic breast cancer who achieve a no‐evidence‐of‐disease status after systemic or local therapy

By  

CANCER, Vol. 121, Iss. 24, 2015-12 ,pp. : 4324-4332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Global abnormalities in lymphatic function following systemic therapy in patients with breast cancer

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 5, 2015-04 ,pp. : 534-540

John Wiley & Sons Inc

Access to resources Recommend Favorite

Critical Appraisal of Primary Systemic Endocrine Therapy in Receptor-Positive Postmenopausal Breast Cancer: An Update

By  

Oncology Research and Treatment, Vol. 29, Iss. 5, 2006-05 ,pp. : 210-217

Karger

Access to resources Recommend Favorite

Adjuvant systemic therapy for elderly women with breast cancer

By Henry N Lynn   Diehl Kathleen M   Hayes Daniel F  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 75-87

Future Medicine

Access to resources Recommend Favorite